Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sodium Valproate 200mg + Valproic Acid 87mg
Therapeutic Category
Neurology, Antiepileptic
Dosage Form
Tablet
Packaging Type
Strip Pack
Packaging
10*10
Price
₹65/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Valpotime CR 300 is a controlled-release formulation containing Sodium Valproate (200mg) and Valproic Acid (87mg). It is primarily prescribed for managing epilepsy and bipolar disorder. This combination of active ingredients works synergistically to control seizures and stabilize mood, providing a dual-action treatment for patients with these conditions.
The controlled-release technology in Valpotime CR 300 ensures that the active ingredients are released slowly and consistently into the bloodstream, leading to stable therapeutic effects throughout the day. This helps minimize side effects that may arise from fluctuating drug levels, improving the patient's adherence to the treatment plan and overall quality of life.
Valpotime CR 300 is particularly beneficial for patients suffering from generalized seizures, focal seizures, and manic episodes related to bipolar disorder. It works by regulating the electrical activity in the brain, thus preventing the abnormal neuronal firing responsible for seizures and stabilizing mood in patients with bipolar disorder.
This medication is designed for long-term management and is best suited for patients who require consistent medication throughout the day, making it an effective solution for both epilepsy and bipolar disorder.
Common side effects include nausea, drowsiness, tremors, dizziness, and weight gain. Severe side effects may include liver problems, blood disorders, or pancreatitis. Immediate medical attention should be sought if these occur.
For the treatment of epilepsy (generalized and focal seizures) and the management of bipolar disorder.
Consult your doctor before use if you have liver disease, are pregnant or breastfeeding. Regular blood tests are required during treatment to monitor liver function and blood counts.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Divalproex (250mg) Prolonged Release
Composition : Divalproex (500mg) Prolonged Release Tablet
Composition : Duloxetine (20mg)
Composition : Duloxetine (30mg) Tablet
Composition : Duloxetine (40mg) Tablet
Composition : Duloxetine (60mg) Tablet
Composition : Gabapentin (400mg) + Nortriptyline Hydrochloride (10mg)
Composition : Oxcarbazepine I.P. 300mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sodium Valproate + Valproic Acid Tablet is an antiepileptic and mood stabilizer used in the management of epilepsy, generalized and partial seizures, bipolar disorder, and migraine prevention. It works by increasing brain levels of GABA (gamma-aminobutyric acid), which helps reduce abnormal nerve activity and stabilizes mood. This makes it an important medicine in the neurology and psychiatry segment.
Medical distributors and wholesalers can benefit from consistent and long-term demand from neurologists, psychiatrists, and physicians. Neurological and psychiatric conditions often require lifelong therapy, ensuring steady prescriptions, repeat purchases, and stable business growth.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in neurology, psychiatry, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high chronic therapy adherence, strong specialist-driven prescriptions, and growing mental health awareness, making it a stable, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in neurology and psychiatry products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the neurological and mental health segment.